ID

24054

Descripción

Comparison of Biphasic Insulin Aspart 30 Versus Insulin Glargine Both in Combination With Metformin and Glimepiride in Subjects With Type 2 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT00469092

Link

https://clinicaltrials.gov/show/NCT00469092

Palabras clave

Versiones (1)
  1. 24/7/17 24/7/17 -
Subido en

24 de julio de 2017

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Diabetes NCT00469092

Inglés

Eligibility Diabetes NCT00469092

1 formularios  
  1. StudyEvent: Eligibility
    1. Eligibility Diabetes NCT00469092
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
type 2 diabetes
Descripción

Diabetes Mellitus, Non-Insulin-Dependent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0011860
treatment with oads (oral anti-diabetic drugs) for more than 6 months
Descripción

Antidiabetics Oral

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0935929
UMLS CUI [1,2]
C1527415
ongoing stable treatment with metformin for at least 2 months
Descripción

Metformin

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0025598
ongoing stable treatment with minimum half maximal dose of any insulin secretagogue for at least 2 months
Descripción

Pills Insulin Releasing | Dose Stable

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0994475
UMLS CUI [1,2]
C0021641
UMLS CUI [1,3]
C1283071
UMLS CUI [2,1]
C0178602
UMLS CUI [2,2]
C0205360
insulin naive
Descripción

Insulin naive

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0021641
UMLS CUI [1,2]
C0919936
hba1c (glycosylated haemoglobin a1c) between 7.0% and 11.0% (inclusive of both values)
Descripción

Glycosylated hemoglobin A

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0019018
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
metformin contraindication according to local practice
Descripción

Medical contraindication Metformin

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1301624
UMLS CUI [1,2]
C0025598
tzd (thiazolidinedione) treatment for the last 5 months before trial start
Descripción

Thiazolidinediones

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1257987
systemic treatment with any corticosteroid 3 months before trial start
Descripción

Systemic Corticosteroid Therapy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C4053960
any disease or condition which according to the investigator would interfere with the trial
Descripción

Disease Interferes with Clinical Trial | Condition Interferes with Clinical Trial

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C0521102
UMLS CUI [1,3]
C0008976
UMLS CUI [2,1]
C0348080
UMLS CUI [2,2]
C0521102
UMLS CUI [2,3]
C0008976
Volver a la parte superior de la página

Similar models

Eligibility Diabetes NCT00469092

1 formularios
  1. StudyEvent: Eligibility
    1. Eligibility Diabetes NCT00469092
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Diabetes Mellitus, Non-Insulin-Dependent
Item
type 2 diabetes
boolean
C0011860 (UMLS CUI [1])
Antidiabetics Oral
Item
treatment with oads (oral anti-diabetic drugs) for more than 6 months
boolean
C0935929 (UMLS CUI [1,1])
C1527415 (UMLS CUI [1,2])
Metformin
Item
ongoing stable treatment with metformin for at least 2 months
boolean
C0025598 (UMLS CUI [1])
Pills Insulin Releasing | Dose Stable
Item
ongoing stable treatment with minimum half maximal dose of any insulin secretagogue for at least 2 months
boolean
C0994475 (UMLS CUI [1,1])
C0021641 (UMLS CUI [1,2])
C1283071 (UMLS CUI [1,3])
C0178602 (UMLS CUI [2,1])
C0205360 (UMLS CUI [2,2])
Insulin naive
Item
insulin naive
boolean
C0021641 (UMLS CUI [1,1])
C0919936 (UMLS CUI [1,2])
Glycosylated hemoglobin A
Item
hba1c (glycosylated haemoglobin a1c) between 7.0% and 11.0% (inclusive of both values)
boolean
C0019018 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Medical contraindication Metformin
Item
metformin contraindication according to local practice
boolean
C1301624 (UMLS CUI [1,1])
C0025598 (UMLS CUI [1,2])
Thiazolidinediones
Item
tzd (thiazolidinedione) treatment for the last 5 months before trial start
boolean
C1257987 (UMLS CUI [1])
Systemic Corticosteroid Therapy
Item
systemic treatment with any corticosteroid 3 months before trial start
boolean
C4053960 (UMLS CUI [1])
Disease Interferes with Clinical Trial | Condition Interferes with Clinical Trial
Item
any disease or condition which according to the investigator would interfere with the trial
boolean
C0012634 (UMLS CUI [1,1])
C0521102 (UMLS CUI [1,2])
C0008976 (UMLS CUI [1,3])
C0348080 (UMLS CUI [2,1])
C0521102 (UMLS CUI [2,2])
C0008976 (UMLS CUI [2,3])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial